{"id":51086,"date":"2023-09-20T09:17:16","date_gmt":"2023-09-20T09:17:16","guid":{"rendered":"https:\/\/medsname.com\/nevimune\/"},"modified":"2026-05-16T05:24:27","modified_gmt":"2026-05-16T05:24:27","slug":"nevimune","status":"publish","type":"product","link":"https:\/\/medsbase.com\/ro\/product\/nevimune\/","title":{"rendered":"Nevimune"},"content":{"rendered":"<div class=\"medsbase-tldr-answer\" style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:14px 18px;margin:18px 0;border-radius:4px;\">\n<h3 style=\"margin-top:0;\">R\u0103spuns rapid<\/h3>\n<p style=\"margin-bottom:0;\"><strong>Nevimune<\/strong> \u2014 Nevirapine 200 mg (Cipla Inc). NNRTI pentru HIV. Doz\u0103 ini\u021bial\u0103 200 mg\/zi \u00d7 14 zile, apoi 200 mg de dou\u0103 ori pe zi. Avertisment cut\u0103 negru pentru hepatotoxicitate sever\u0103 \u0219i erup\u021bii cutanate, mai ales la femei cu CD4 &gt;250 \u0219i b\u0103rba\u021bi cu CD4 &gt;400.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f7f7f7;border-left:4px solid #2c7cb0;padding:14px 18px;margin:18px 0;border-radius:4px;\">\n<p style=\"margin:0 0 6px 0;\"><strong>Ce beneficii ofer\u0103 MedsBase:<\/strong><\/p>\n<ul style=\"margin:6px 0 0 22px;padding:0;list-style:disc;\">\n<li>produc\u0103tor certificat WHO-GMP<\/li>\n<li>Ambalaj discret \u00een plic simplu<\/li>\n<li>Livrare \u00een toat\u0103 lumea<\/li>\n<li>Evaluat de peste 1.400 de clien\u021bi (<a href=\"https:\/\/medsbase.com\/ro\/reviews\/\">cite\u0219te recenziile<\/a>)<\/li>\n<\/ul>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"background:#eef7ee;border-left:4px solid #4caf50;padding:10px 14px;margin:14px 0;border-radius:3px;\">\ud83d\udce6 <strong>Garan\u021bia de retransmitere:<\/strong> dac\u0103 comanda dvs. nu a ajuns \u00een 20 de zile lucr\u0103toare de la expediere, o retransmitem f\u0103r\u0103 costuri suplimentare. <a href=\"https:\/\/medsbase.com\/ro\/medsbase-re-shipment-assurance-policy\/\">Cite\u0219te politica<\/a>.<\/p>\n<h3>De ce s\u0103 comanzi de la MedsBase<\/h3>\n<p>Nevimune este expediat de la un produc\u0103tor certificat WHO-GMP \u00een ambalaj neutru, facturat prin procesator de plat\u0103 reglementat (descrierea extrasului de cont men\u021bioneaz\u0103 un procesator de plat\u0103 reglementat \u2014 niciodat\u0103 MedsBase sau nume de medicamente). Fiecare comand\u0103 beneficiaz\u0103 de Asigurarea noastr\u0103 de Reexpediere \u00een 20 de zile lucr\u0103toare.<\/p>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:12px 16px;margin:14px 0;border-radius:3px;\"><strong>Barier\u0103 genetic\u0103 sc\u0103zut\u0103 la rezisten\u021b\u0103<\/strong><br \/>NNRTI-urile de prima genera\u021bie (nevirapina, efavirenzul) au o barier\u0103 genetic\u0103 sc\u0103zut\u0103 \u2014 o singur\u0103 muta\u021bie punctiform\u0103 (K103N pentru efavirenz; Y181C pentru nevirapin\u0103) confer\u0103 rezisten\u021b\u0103 ridicat\u0103. Este obligatorie o aderen\u021b\u0103 strict\u0103 &gt;95%. Rezisten\u021ba la un NNRTI confer\u0103 rezisten\u021b\u0103 \u00eencruci\u0219at\u0103 \u00eentreaga clas\u0103.<\/div>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:12px 16px;margin:14px 0;border-radius:3px;\"><strong>Nevirapin\u0103 \u2014 reac\u021bii hepatice \u0219i cutanate severe<\/strong><br \/>Nevirapina poart\u0103 un avertisment FDA (black-box) pentru hepatotoxicitate sever\u0103 (\u00een special la femei cu CD4 &gt;250 \u0219i b\u0103rba\u021bi cu CD4 &gt;400), erup\u021bii cutanate severe, sindrom Stevens-Johnson \u0219i DRESS. Doza ini\u021bial\u0103 (200 mg\/zi \u00d7 14 zile, apoi 200 mg de 2 ori\/zi) reduce dar nu elimin\u0103 riscul. \u00centrerupe\u021bi imediat la apari\u021bia erup\u021biei cu simptome sistematice sau LFT &gt;5\u00d7 ULN.<\/div>\n<h2>Cum ac\u021bioneaz\u0103 NNRTI-urile<\/h2>\n<p>Inhibitorii non-nucleozidici de transcriptaz\u0103 invers\u0103 se leag\u0103 de un buzunar hidrofob pe transcriptaza invers\u0103 a HIV, distinct de situsul activ al NRTI. Acestea distorsioneaz\u0103 alosteric enzima. NNRTI-urile sunt necompetitive \u0219i NU necesit\u0103 fosforilare intracelular\u0103.<\/p>\n<p>Regimurile bazate pe NNRTI (de obicei cu dou\u0103 NRTI) au fost un pilon al terapiei ART de prim\u0103 linie la nivel mondial timp de mul\u021bi ani. Ghidurile moderne prefer\u0103 acum inhibitorii de transfer de caten\u0103 integraz\u0103 (INSTI) ca prim\u0103 linie, cu NNRTI-uri ca alternative \u00een medii cu resurse limitate sau unde INSTI-urile nu sunt disponibile.<\/p>\n<h2 id=\"faqs\">\u00centreb\u0103ri frecvente<\/h2>\n<h3>De ce a sc\u0103zut utilizarea NNRTI?<\/h3>\n<p>Ghidurile moderne prefer\u0103 inhibitorii de transfer de caten\u0103 integraz\u0103 (dolutegravir, raltegravir, bictegravir) ca ART de prim\u0103 linie datorit\u0103 barierei genetice mai ridicate la rezisten\u021b\u0103, tolerabilit\u0103\u021bii mai bune \u0219i a mai pu\u021binelor interac\u021biuni medicamentoase. NNRTI-urile r\u0103m\u00e2n utilizate pe scar\u0103 larg\u0103 \u00een medii cu resurse limitate \u0219i unde INSTI-urile nu sunt disponibile.<\/p>\n<h3>Efecte secundare?<\/h3>\n<p>Clasa: erup\u021bii cutanate (10-20%, adesea u\u0219oare dar pot fi severe), efecte CNS (efavirenz), cre\u0219teri ale enzimelor hepatice, tulbur\u0103ri gastrointestinale. Specifice: vise vii \u0219i depresie la efavirenz; erup\u021bii cutanate severe \u0219i hepatotoxicitate la nevirapin\u0103; rilpivirin\u0103 bine tolerat\u0103 dar PPI contraindicat.<\/p>\n<h3>Ce spune\u021bi despre rezisten\u021b\u0103?<\/h3>\n<p>NNRTI-urile au o barier\u0103 genetic\u0103 sc\u0103zut\u0103 \u2014 o singur\u0103 muta\u021bie poate conferi rezisten\u021b\u0103 la \u00eentreaga clas\u0103. Respectarea strict\u0103 a tratamentului este critic\u0103.<\/p>\n<h3>Interac\u021biuni medicamentoase?<\/h3>\n<p>Majoritatea NNRTI-lor sunt inductori ai CYP3A4 (efavirenz, nevirapin\u0103) sau substraturi (rilpivirin\u0103). Numeroase interac\u021biuni: rifampicina necesit\u0103 ajustare de doz\u0103, PPI-uri sunt contraindicate cu rilpivirin\u0103, metadona necesit\u0103 cre\u0219tere de doz\u0103 cu efavirenz.<\/p>\n<h3>Sarcin\u0103?<\/h3>\n<p>Efavirenzul este \u00een general sigur \u00een sarcin\u0103 (dup\u0103 ani de precau\u021bie privind defectele tubului neural, datele agregate nu arat\u0103 risc crescut). Nevirapina este sigur\u0103 dar cu utilizare limitat\u0103 \u00een regiuni bogate \u00een resurse datorit\u0103 riscului sever de erup\u021bie cutanat\u0103\/hepatotoxicitate la femeile cu CD4 &gt;250. Rilpivirina are date rezonabile privind sarcina.<\/p>\n<h3>Conformitate?<\/h3>\n<p>&gt;95% necesar. Dozele ratate cu NNRTI selecteaz\u0103 rapid rezisten\u021b\u0103 datorit\u0103 barierii genetice sc\u0103zute. Discuta\u021bi \u00eentotdeauna provoc\u0103rile de conformitate cu echipa de HIV devreme \u2014 sunt disponibile regimuri alternative.<\/p>\n<h3>Ce fac dac\u0103 uit o doz\u0103?<\/h3>\n<p>Lua\u021bi c\u00e2nd v\u0103 aminti\u021bi dac\u0103 \u00eent\u00e2rziere 6 ore, omite\u021bi \u0219i relua\u021bi programul normal \u2014 nu lua\u021bi doblu.<\/p>\n<h3>Coinfec\u021bie cu HBV?<\/h3>\n<p>NNRTI nu trateaz\u0103 HBV. Spatele NRTI (TDF + FTC sau 3TC) trateaz\u0103 at\u00e2t HIV c\u00e2t \u0219i HBV \u2014 p\u0103stra\u021bi aceast\u0103 combina\u021bie dac\u0103 co-infec\u021bia cu HBV. Oprirea brusc\u0103 poate declan\u0219a exacerbare HBV.<\/p>\n<h3>Tratament pe via\u021b\u0103?<\/h3>\n<p>Da. Oprirea ART permite revenirea viral\u0103 \u00een c\u00e2teva s\u0103pt\u0103m\u00e2ni. Terapia consistent\u0103 ofer\u0103 speran\u021b\u0103 de via\u021b\u0103 aproape normal\u0103 \u0219i U=U (Nedetectabil = Netransmisibil).<\/p>\n<h3>C\u00e2nd ar trebui s\u0103 consult echipa mea de HIV?<\/h3>\n<p>\u00cengrijirea rutin\u0103 HIV: \u00eenc\u0103rc\u0103tur\u0103 viral\u0103 + CD4 la 3-6 luni odat\u0103 stabilizat, screening anual pentru ITS, actualiz\u0103ri vaccinare, screening lipidic\/glucidic\/renal. Mai devreme dac\u0103 simptomele sugereaz\u0103 e\u0219ec terapeutic sau efect advers.<\/p>\n<p class=\"medsbase-link-boost-2026-05-16\" data-marker=\"mb-link-boost-ricovir-em\"><a href=\"https:\/\/medsbase.com\/ro\/what-is-hiv-prep-and-how-does-it-work\/\">Nevimune (nevirapin\u0103)<\/a> este NNRTI-ul din linia secundar\u0103 ART a OMS; spatele NRTI cu care se asociaz\u0103 cel mai des este <a href=\"https:\/\/medsbase.com\/ro\/ricovir-em\/\">Ricovir-EM (tenofovir DF 300 mg + emtricitabin\u0103 200 mg)<\/a> \u2014 aceea\u0219i combina\u021bie fix\u0103 tenofovir\/FTC utilizat\u0103 pentru PrEP HIV.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h2>Alte medicamente HIV \u0219i antivirale<\/h2>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/trioday\/\">Trioday<\/a> \u2014 TDF + 3TC + EFV \u2014 regim cu o singur\u0103 tablet\u0103 de la Cipla<\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/triomune\/\">Triomune<\/a> \u2014 d4T + 3TC + NVP \u2014 regim mai vechi 3-\u00een-1 (pe baz\u0103 de stavudin\u0103)<\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/zepdon\/\">Zepdon<\/a> \u2014 raltegravir 400 mg \u2014 inhibitor de integraz\u0103<\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/abamune-l\/\">Abamune L<\/a> \u2014 abacavir + lamivudin\u0103 \u2014 alternativ\u0103 pentru scheletul NRTI<\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/tenvir-l\/\">Tenvir L<\/a> \u2014 tenofovir + lamivudine \u2014 alternativ\u0103 de baz\u0103 NRTI<\/li>\n<\/ul>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:12px 16px;margin:18px 0;border-radius:3px;font-size:.95em;\"><strong>Disclaimer medical:<\/strong> Tratamentul HIV este o terapie complex\u0103 \u0219i pe termen lung. Alegerea medicamentului depinde de genotip, teste de rezisten\u021b\u0103, comorbidit\u0103\u021bi \u0219i istoricul tratamentelor anterioare. Discuta\u021bi orice modificare a regimenului cu un specialist \u00een HIV. Este necesar\u0103 o conformitate &gt;95% pentru a preveni rezisten\u021ba. Testa\u021bi pentru HBV \u00eenainte de a \u00eencepe orice regimen care con\u021bine tenofovir, lamivudin\u0103 sau emtricitabin\u0103 \u2014 \u00eentreruperea poate provoca o exacerbare sever\u0103 a HBV la pacien\u021bii cu infec\u021bie mixt\u0103.<\/div>","protected":false},"excerpt":{"rendered":"<p>Nevimune (Nevirapine 200 mg) \u2014 NNRTI de la Cipla pentru HIV-1. Doz\u0103 ini\u021bial\u0103 200 mg\/zi \u00d7 14 zile, apoi 200 mg de dou\u0103 ori pe zi. Avertisment cut\u0103 negru pentru hepatotoxicitate sever\u0103 \u0219i erup\u021bii cutanate, mai ales la pacien\u021bii cu num\u0103r mai mare de CD4.<\/p>","protected":false},"featured_media":51087,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3304],"product_tag":[],"class_list":{"0":"post-51086","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-hiv-medication","10":"first","11":"outofstock","12":"shipping-taxable","13":"purchasable","14":"product-type-variable","15":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product\/51086","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/comments?post=51086"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media\/51087"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media?parent=51086"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_brand?post=51086"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_cat?post=51086"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_tag?post=51086"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}